Qurient Stock Forecast for 2023 - 2025 - 2030
Updated on 05/06/2024
Qurient Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Qurient's Price has increased by 100.00%, going from 0.00 to 0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach 0.00 – an increase of 100.00%. The Qurient forecast is for Fair Value to reach 0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A207940 Stock Forecast | Samsung Biologics | Buy |
7
|
₩771.00k | Buy/Sell | ₩0.00B | 32.94% |
| A068270 Stock Forecast | Celltrion | Outperform |
16
|
₩189.00k | Buy/Sell | ₩215.28k | 21.69% |
| A091990 Stock Forecast | Celltrion Healthcare | - |
12
|
₩75.90k | Buy/Sell | ₩90.17k | -100.00% |
| A196170 Stock Forecast | ALTEOGEN | Buy |
6
|
₩177.20k | Buy/Sell | ₩83.33k | 24.15% |
| A068760 Stock Forecast | Celltrion Pharm | - |
11
|
₩95.60k | Buy/Sell | ₩11.33k | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A141080 Stock Forecast | LegoChem Biosciences | Outperform |
7
|
₩68.00k | Buy/Sell | ₩66.50k | 35.29% |
| A006280 Stock Forecast | GC Biopharma | Buy |
16
|
₩113.50k | Buy/Sell | ₩146.43k | 26.87% |
| A214450 Stock Forecast | PharmaResearch | Outperform |
16
|
₩139.60k | Buy/Sell | ₩165.00k | 25.36% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A298380 Stock Forecast | ABL Bio | Outperform |
6
|
₩25.50k | Buy/Sell | ₩37.00k | 45.10% |
| A007390 Stock Forecast | NatureCell | - |
0
|
₩7.29k | Buy/Sell | ₩0.00 | -100.00% |
| A256840 Stock Forecast | BNC Korea | - |
0
|
₩3.56k | Buy/Sell | ₩0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A214370 Stock Forecast | Caregen | - |
18
|
₩22.20k | Buy/Sell | ₩50.00k | -100.00% |
| A086900 Stock Forecast | Medy-Tox | Outperform |
8
|
₩138.40k | Buy/Sell | ₩335.00k | 167.34% |
| A115450 Stock Forecast | HLB Therapeutics | - |
6
|
₩10.28k | Buy/Sell | ₩20.77k | -100.00% |
Qurient EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Qurient's EBITDA has grown, increasing from -20.48B to -23.58B – a growth of 15.10%. For the next year, 0 analysts project Qurient's EBITDA to drop by 13.12%, reaching -20.48B. By 2030, professionals believe that Qurient's EBITDA will decrease by 7.90%, reaching -21.71B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A293780 Stock Forecast | AptaBio Therapeutics |
0
|
₩7.62k | Buy/Sell | ₩0.00 | -100.00% | |
| A182400 Stock Forecast | NKMAX CO. | - |
7
|
₩5.66k | Buy/Sell | ₩0.00 | -100.00% |
| A041960 Stock Forecast | Komipharm International | - |
6
|
₩4.39k | Buy/Sell | ₩0.00 | -100.00% |
Qurient EBIT Forecast for 2023 - 2025 - 2030
In the last year, Qurient's EBIT has grown by 15.31%, from -21.02B to -24.24B. According to 0 prominent analysts, Qurient's EBIT will fall by 13.27% in the next year, reaching -21.03B. By 2030, professionals believe that Qurient's EBIT will decrease by 7.99%, reaching -22.31B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A087010 Stock Forecast | Peptron | - |
6
|
₩30.60k | Buy/Sell | ₩35.00k | -100.00% |
| A065660 Stock Forecast | Anterogen.Co.,Ltd. | - |
7
|
₩14.01k | Buy/Sell | ₩0.00 | -100.00% |
| A144510 Stock Forecast | GC Cell | - |
11
|
₩37.55k | Buy/Sell | ₩74.00k | -100.00% |
Qurient EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Qurient's EPS has increased by 100.00%, going from 0.00 to 0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach 0.00 – an increase of 100.00%. The Qurient forecast is for EPS to reach 0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A199800 Stock Forecast | ToolGen | - |
0
|
₩69.30k | Buy/Sell | ₩270.00k | -100.00% |
| A031390 Stock Forecast | Green Cross Cell | - |
14
|
₩38.55k | Buy/Sell | ₩80.00k | -100.00% |
| A299660 Stock Forecast | Cellid, | - |
5
|
₩4.27k | Buy/Sell | ₩0.00 | -100.00% |
.jpg)